{"DataElement":{"publicId":"5040178","version":"1","preferredName":"Acute Graft Versus Host Disease Stage Lower Gastrointestinal Tract Severity Type","preferredDefinition":"A description of acute graft versus host disease lower gastrointestinal tract severity stage.","longName":"5040172v1.0:2797629v1.5","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5040172","version":"1","preferredName":"Acute Graft Versus Host Disease Stage","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation._Any distinct time period in a sequence of events.","longName":"2512823v1.0:4843953v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2512823","version":"1","preferredName":"Acute Graft Versus Host Disease","preferredDefinition":"A graft versus host disease with symptoms appearing within the first 100 days post-transplant, but with short duration.","longName":"C4980","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Graft Versus Host Disease","conceptCode":"C4980","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B898438-B0B8-35BB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4843953","version":"1","preferredName":"Stage","preferredDefinition":"Any distinct time period in a sequence of events.","longName":"C48308","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage","conceptCode":"C48308","definition":"Any distinct time period in a sequence of events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177D51D9-1D88-7367-E050-BB89AD433961","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"ONEDATA","dateModified":"2015-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23428223-EDB0-0C35-E050-BB89AD430FC5","latestVersionIndicator":"Yes","beginDate":"2015-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-29","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2797629","version":"1.5","preferredName":"Acute Graft Versus Host Disease Lower Gastrointestinal Tract Severity Type","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation._The lower part of the gastrointestinal tract that includes the jejunum and ileum of the small intestine and the large intestine._Used of the degree of something undesirable e.g. pain or weather; also, strictness._Type; a subdivision of a particular kind of thing.","longName":"2797629v1.5","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage 0","valueDescription":"AGVHD Lower GI Stage 0","ValueMeaning":{"publicId":"5132098","version":"1","preferredName":"AGVHD Lower GI Stage 0","longName":"5132098","preferredDefinition":"No diarrhea, no diarrhea attributable to acute GVHD / diarrhea < 500 mL/day (adult), or < 10 mL/kg/day (pediatric)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C868267-46FC-475A-E050-BB89AD4350B6","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C868267-4715-475A-E050-BB89AD4350B6","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","deletedIndicator":"No"},{"value":"Stage 4","valueDescription":"AGVHD Lower GI Stage 4","ValueMeaning":{"publicId":"5132094","version":"1","preferredName":"AGVHD Lower GI Stage 4","longName":"5132094","preferredDefinition":"Severe abdominal pain, with or without ileus, and/or grossly bloody stool","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C868267-4670-475A-E050-BB89AD4350B6","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C868267-4689-475A-E050-BB89AD4350B6","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","deletedIndicator":"No"},{"value":"Stage 3","valueDescription":"AGVHD Lower GI Stage 3","ValueMeaning":{"publicId":"5132095","version":"1","preferredName":"AGVHD Lower GI Stage 3","longName":"5132095","preferredDefinition":"Diarrhea > 1500 mL/day (adult), or > 30 mL/kg/day (pediatric)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C868267-4693-475A-E050-BB89AD4350B6","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C868267-46AC-475A-E050-BB89AD4350B6","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","deletedIndicator":"No"},{"value":"Stage 2","valueDescription":"AGVHD Lower GI Stage 2","ValueMeaning":{"publicId":"5132096","version":"1","preferredName":"AGVHD Lower GI Stage 2","longName":"5132096","preferredDefinition":"Diarrhea 1001 - 1500 mL/day (adult), or 20 - 30 mL/kg/day (pediatric)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C868267-46B6-475A-E050-BB89AD4350B6","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C868267-46CF-475A-E050-BB89AD4350B6","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","deletedIndicator":"No"},{"value":"Stage 1","valueDescription":"AGVHD Lower GI Stage 1","ValueMeaning":{"publicId":"5132097","version":"1","preferredName":"AGVHD Lower GI Stage 1","longName":"5132097","preferredDefinition":"Diarrhea 500 - 1000 mL/day (adult), or 10 - 19.9 mL/kg/day (pediatric)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C868267-46D9-475A-E050-BB89AD4350B6","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C868267-46F2-475A-E050-BB89AD4350B6","beginDate":"2016-02-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2955346","version":"1","preferredName":"Acute Graft Versus Host Disease Lower Gastrointestinal Tract Severity Type","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation.:The lower part of the gastrointestinal tract that includes the jejunum and ileum of the small intestine and the large intestine.:Severity; used of the degree of something undesirable e.g. pain or weather.:Type; a subdivision of a particular kind of thing.","longName":"C4980:C33010:C25676:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Graft Versus Host Disease","conceptCode":"C4980","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Lower Gastrointestinal Tract","conceptCode":"C33010","definition":"The lower part of the gastrointestinal tract that includes the jejunum and ileum of the small intestine and the large intestine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7674A00C-2736-DFA8-E040-BB89AD4317DA","latestVersionIndicator":"Yes","beginDate":"2009-10-21","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-21","modifiedBy":"ONEDATA","dateModified":"2009-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23422EED-C52A-4CEA-E050-BB89AD437155","latestVersionIndicator":"Yes","beginDate":"2015-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-29","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2793652","version":"1","longName":"PhenX","context":"PhenX","ClassificationSchemeItems":[{"publicId":"4809631","version":"1","longName":"Sickle Cell Disease Collection","context":"PhenX"},{"publicId":"7765018","version":"1","longName":"Curative Therapies","context":"PhenX"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685478","version":"1","longName":"Testing Set – Moderately Different","context":"NCIP"}]}],"AlternateNames":[{"name":"PhenX","type":"USED_BY","context":"PhenX"},{"name":"HPST_AGHD_agvhd_stge_low_intes","type":"NMDP_FN","context":"NHLBI"},{"name":"TPST_GVHD_agvhd_stge_low_intes","type":"NMDP_FN","context":"NHLBI"},{"name":"CPST_GVHD_agvhd_stge_low_intes","type":"NMDP_FN","context":"NHLBI"},{"name":"AGVHD_LOWER_GI_STAGE","type":"COG GDE Short Name","context":"COG"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"TPST_GVHD_dx_agvhd_stge_low_in","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedClinicalInterpretation:severityCode","type":"HCT_BRIDG_5","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the acute graft vers","type":"Preferred Question Text","description":"What was the acute graft versus host disease lower gastrointestinal tract severity stage?","url":null,"context":"NHLBI"},{"name":"Lower intestinal tract","type":"Alternate Question Text","description":"Lower intestinal tract","url":null,"context":"NHLBI"},{"name":"Lower intestinal tract","type":"Application Standard Question Text","description":"Lower intestinal tract","url":null,"context":"NHLBI"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"If lower GI involvement indicated by site, confirm stage for this reporting period:","url":null,"context":"COG"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23428223-EE3E-0C35-E050-BB89AD430FC5","latestVersionIndicator":"Yes","beginDate":"2015-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-29","modifiedBy":"PANH","dateModified":"2021-08-13","changeDescription":"Added HCT_BRIDG5 alternate name - RR 2018-12-21 Added FN for 2450. AK 6/6/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}